カテゴリー： QYResearch, 世界

血管内皮増殖因子(VEGF)阻害剤の世界市場：規模・現状・予測2019-2025

【英語タイトル】Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料（DATA909X19071）・商品コード：DATA909X19071
・発行会社（調査会社）：QYResearch
・発行日：2019年11月25日（※2024年版があります。お問い合わせください）
・ページ数：91
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥577,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥865,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥1,154,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※当調査レポートでは、血管内皮増殖因子(VEGF)阻害剤の世界市場について調査・分析し、血管内皮増殖因子(VEGF)阻害剤の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（VEGF-A阻害剤、VEGF-B阻害剤、VEGF-C阻害剤、VEGF-D阻害剤）、用途別（腫瘍学、眼科）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界の血管内皮増殖因子(VEGF)阻害剤市場動向
・主要企業別マーケットシェア
・血管内皮増殖因子(VEGF)阻害剤の種類別市場規模2014-2019
（VEGF-A阻害剤、VEGF-B阻害剤、VEGF-C阻害剤、VEGF-D阻害剤）
・血管内皮増殖因子(VEGF)阻害剤の用途別市場規模2014-2019
（腫瘍学、眼科）
・血管内皮増殖因子(VEGF)阻害剤の北米市場：主要企業・種類別/用途別市場規模
・血管内皮増殖因子(VEGF)阻害剤のヨーロッパ市場：主要企業・種類別/用途別市場規模
・血管内皮増殖因子(VEGF)阻害剤の中国市場：主要企業・種類別/用途別市場規模
・血管内皮増殖因子(VEGF)阻害剤の日本国内市場：主要企業・種類別/用途別市場規模
・血管内皮増殖因子(VEGF)阻害剤の東南アジア市場：主要企業・種類別/用途別市場規模
・血管内皮増殖因子(VEGF)阻害剤のインド市場：主要企業・種類別/用途別市場規模
・血管内皮増殖因子(VEGF)阻害剤の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Bayer AG、F. Hoffmann-La Roche Ltd.、Novartis AG、Regeneron Pharmaceuticals Inc.、Sanofi.）
・血管内皮増殖因子(VEGF)阻害剤の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...
【レポートの概要】

Vascular endothelial growth factor inhibitors, also known as angiogenesis inhibitors, can prevent the generation of new blood vessels. The vascular endothelial growth factor is a protein that can trigger endothelial cells or pre-existing vessels to form new blood vessels. However, overexpression of vascular endothelial growth factor can generate cancerous cells.
In 2018, the global Vascular Endothelial Growth Factor (VEGF) Inhibitors market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Vascular Endothelial Growth Factor (VEGF) Inhibitors status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Vascular Endothelial Growth Factor (VEGF) Inhibitors development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Bayer AG
F. Hoffmann-La Roche Ltd.
Novartis AG
Regeneron Pharmaceuticals Inc.
Sanofi.
…

Market segment by Type, the product can be split into
VEGF-A Inhibitor
VEGF-B Inhibitor
VEGF-C Inhibitor
VEGF-D Inhibitor

Market segment by Application, split into
Oncology
Ophthalmology

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Vascular Endothelial Growth Factor (VEGF) Inhibitors status, future forecast, growth opportunity, key market and key players.
To present the Vascular Endothelial Growth Factor (VEGF) Inhibitors development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Vascular Endothelial Growth Factor (VEGF) Inhibitors are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate by Type (2014-2025)
1.4.2 VEGF-A Inhibitor
1.4.3 VEGF-B Inhibitor
1.4.4 VEGF-C Inhibitor
1.4.5 VEGF-D Inhibitor
1.5 Market by Application
1.5.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application (2019-2025)
1.5.2 Oncology
1.5.3 Ophthalmology
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size
2.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Growth Trends by Regions
2.2.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Regions (2019-2025)
2.2.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by by Players
3.1.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue by by Players (2014-2019)
3.1.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by by Players (2014-2019)
3.1.3 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Concentration Ratio (CR5 and HHI)
3.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Players Head office and Area Served
3.3 Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Product/Solution/Service
3.4 Date of Enter into Vascular Endothelial Growth Factor (VEGF) Inhibitors Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2014-2019)
4.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2014-2019)

5 North America
5.1 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2014-2019)
5.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Players in North America
5.3 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
5.4 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application

6 Europe
6.1 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2014-2019)
6.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Players in Europe
6.3 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
6.4 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application

7 China
7.1 China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2014-2019)
7.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Players in China
7.3 China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
7.4 China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application

8 Japan
8.1 Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2014-2019)
8.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Players in Japan
8.3 Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
8.4 Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2014-2019)
9.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Players in Southeast Asia
9.3 Southeast Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
9.4 Southeast Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application

10 India
10.1 India Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2014-2019)
10.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Players in India
10.3 India Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
10.4 India Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application

11 Central & South America
11.1 Central & South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2014-2019)
11.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Players in Central & South America
11.3 Central & South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
11.4 Central & South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application

12 International Players Profiles
12.1 Bayer AG
12.1.1 Bayer AG Company Details
12.1.2 Company Description and Business Overview
12.1.3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Introduction
12.1.4 Bayer AG Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2014-2019))
12.1.5 Bayer AG Recent Development
12.2 F. Hoffmann-La Roche Ltd.
12.2.1 F. Hoffmann-La Roche Ltd. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Introduction
12.2.4 F. Hoffmann-La Roche Ltd. Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2014-2019)
12.2.5 F. Hoffmann-La Roche Ltd. Recent Development
12.3 Novartis AG
12.3.1 Novartis AG Company Details
12.3.2 Company Description and Business Overview
12.3.3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Introduction
12.3.4 Novartis AG Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2014-2019)
12.3.5 Novartis AG Recent Development
12.4 Regeneron Pharmaceuticals Inc.
12.4.1 Regeneron Pharmaceuticals Inc. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Introduction
12.4.4 Regeneron Pharmaceuticals Inc. Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2014-2019)
12.4.5 Regeneron Pharmaceuticals Inc. Recent Development
12.5 Sanofi.
12.5.1 Sanofi. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Introduction
12.5.4 Sanofi. Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2014-2019)
12.5.5 Sanofi. Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Market Segments
Table Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Covered
Table Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer VEGF-A Inhibitor Figures
Table Key Players of VEGF-A Inhibitor
Figuer VEGF-B Inhibitor Figures
Table Key Players of VEGF-B Inhibitor
Figuer VEGF-C Inhibitor Figures
Table Key Players of VEGF-C Inhibitor
Figuer VEGF-D Inhibitor Figures
Table Key Players of VEGF-D Inhibitor
Table Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application in 2018 & 2025
Figure Oncology Case Studies
Figure Ophthalmology Case Studies
Figure Vascular Endothelial Growth Factor (VEGF) Inhibitors Report Years Considered
Figure Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Regions 2019-2025 (Million US$)
Table Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Regions 2019-2025 (Million US$)
Table Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Regions 2014-2019
Figure Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Regions 2014-2019
Figure Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue by by Players (2014-2019) (Million US$)
Table Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by by Players (2014-2019)
Figure Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by by Players in 2018
Table Global Vascular Endothelial Growth Factor (VEGF) Inhibitors by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Product/Solution/Service
Table Date of Enter into Vascular Endothelial Growth Factor (VEGF) Inhibitors Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2014-2019) (Million US$)
Table Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Share by Type (2014-2019)
Figure Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Type (2014-2019)
Table Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2014-2019) (Million US$)
Table Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Share by Application (2014-2019)
Figure Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Application (2014-2019)
Figure Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Application in 2018
Figure North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2014-2019 (Million US$)
Table North America Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue (2018-2019) (Million US$)
Table North America Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share (2018-2019)
Table North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type 2014-2019 (Million US$)
Table North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type 2014-2019
Table North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application 2014-2019 (Million US$)
Table North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application 2014-2019
Figure Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2014-2019 (Million US$)
Table Europe Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue (2018-2019) (Million US$)
Table Europe Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share (2018-2019)
Table Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type 2014-2019 (Million US$)
Table Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type 2014-2019
Table Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application 2014-2019 (Million US$)
Table Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application 2014-2019
Figure China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2014-2019 (Million US$)
Table China Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue (2018-2019) (Million US$)
Table China Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share (2018-2019)
Table China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type 2014-2019 (Million US$)
Table China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type 2014-2019
Table China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application 2014-2019 (Million US$)
Table China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application 2014-2019
Figure Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2014-2019 (Million US$)
Table Japan Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue (2018-2019) (Million US$)
Table Japan Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share (2018-2019)
Table Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type 2014-2019 (Million US$)
Table Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type 2014-2019
Table Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application 2014-2019 (Million US$)
Table Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application 2014-2019
Figure Southeast Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share (2018-2019)
Table Southeast Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type 2014-2019
Table Southeast Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application 2014-2019
Figure India Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2014-2019 (Million US$)
Table India Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue (2018-2019) (Million US$)
Table India Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share (2018-2019)
Table India Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type 2014-2019 (Million US$)
Table India Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type 2014-2019
Table India Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application 2014-2019 (Million US$)
Table India Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application 2014-2019
Figure Central & South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share (2018-2019)
Table Central & South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type 2014-2019 (Million US$)
Table Central & South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Type 2014-2019
Table Central & South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application 2014-2019 (Million US$)
Table Central & South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share by Application 2014-2019
Table Bayer AG Company Details
Table Bayer AG Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business 2014-2019 (Million US$)
Figure Bayer AG Revenue Growth Rate in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2014-2019)
Table Bayer AG Recent Development
Table F. Hoffmann-La Roche Ltd. Company Details
Table F. Hoffmann-La Roche Ltd. Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business 2014-2019 (Million US$)
Figure F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2014-2019)
Table F. Hoffmann-La Roche Ltd. Recent Development
Table Novartis AG Company Details
Table Novartis AG Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business 2014-2019 (Million US$)
Figure Novartis AG Revenue Growth Rate in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2014-2019)
Table Novartis AG Recent Development
Table Regeneron Pharmaceuticals Inc. Company Details
Table Regeneron Pharmaceuticals Inc. Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business 2014-2019 (Million US$)
Figure Regeneron Pharmaceuticals Inc. Revenue Growth Rate in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2014-2019)
Table Regeneron Pharmaceuticals Inc. Recent Development
Table Sanofi. Company Details
Table Sanofi. Revenue in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business 2014-2019 (Million US$)
Figure Sanofi. Revenue Growth Rate in Vascular Endothelial Growth Factor (VEGF) Inhibitors Business (2014-2019)
Table Sanofi. Recent Development
Table Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Regions (Million US$) 2019-2025
Figure Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Share by Regions (2019-2025)
Figure Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Share by Regions in 2025
Figure North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure India Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast (2019-2025)(Million USD)
Table Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Product (2019-2025) (Million US$)
Figure Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Product (2019-2025)
Figure Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Product in 2025
Table Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2019-2025) (Million US$)
Figure Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2019-2025)
Figure Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Bayer AG、F. Hoffmann-La Roche Ltd.、Novartis AG、Regeneron Pharmaceuticals Inc.、Sanofi.

★調査レポート[血管内皮増殖因子(VEGF)阻害剤の世界市場：規模・現状・予測2019-2025] (コード：DATA909X19071)販売に関する免責事項を必ずご確認ください。
★調査レポート[血管内皮増殖因子(VEGF)阻害剤の世界市場：規模・現状・予測2019-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • BCL-2（B細胞リンパ腫2）阻害剤の世界市場：規模・現状・予測2019-2025
    DATA909X18213 / QYResearch / 2019年11月25日 / ※当調査レポートでは、BCL-2（B細胞リンパ腫2）阻害剤の世界市場について調査・分析し、BCL-2（B細胞リンパ腫2）阻害剤の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（併用療法、単剤療法）、用途別（陽性リンパ腫、濾胞性リンパ腫、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のBCL-2（B細胞リンパ腫2）阻害剤市場動向 ・主要企業別マーケットシェア ・BCL-2（B細胞リンパ腫2）阻害剤の種類別市場規模2014-2019 （併用療法、単剤療法） ・BCL-2（B細胞リンパ腫2）阻害剤の用途別市場規模2014-2019 （陽性リンパ腫、濾胞性リンパ腫、その他） ・BCL-2（B細胞リンパ腫2）阻害剤の北米市場：主要企業・種類別/用途別市場規模 ・BCL-2（B細胞リンパ腫2）阻害剤のヨーロッパ市場：主要企業・種類別/用途別市場規模...Symptoms of hematologic malignancies are usually mild or inconspicuous, leading to delays in diagnosis and treatment of indications.BCL-2 (B-cell lymphoma 2) inhibitors  regulates the correlation of cell apoptosis at the mitochondrial level, which has the potential to be a therapeutic target for hematologic malignancies.In 2018, the global BCL-2 (B-cell lymphoma 2) Inhibitors market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global BCL-2 (B-cell lymphoma 2) Inhibitors status, future forecast, growth opportunity, key market and key players....
  • PARP（ポリADPリボースポリメラーゼ）阻害剤の世界市場：規模・現状・予測2019-2025
    DATA909X18797 / QYResearch / 2019年11月25日 / ※当調査レポートでは、PARP（ポリADPリボースポリメラーゼ）阻害剤の世界市場について調査・分析し、PARP（ポリADPリボースポリメラーゼ）阻害剤の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（オラパリブ、タラゾパリブ）、用途別（卵巣がん、乳がん、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のPARP（ポリADPリボースポリメラーゼ）阻害剤市場動向 ・主要企業別マーケットシェア ・PARP（ポリADPリボースポリメラーゼ）阻害剤の種類別市場規模2014-2019 （オラパリブ、タラゾパリブ） ・PARP（ポリADPリボースポリメラーゼ）阻害剤の用途別市場規模2014-2019 （卵巣がん、乳がん、その他） ・PARP（ポリADPリボースポリメラーゼ）阻害剤の北米市場：主要企業・種類別/用途別市場規模 ・PARP（ポリADPリボースポリメラーゼ）阻害剤のヨーロッパ市場：主要企業・種類別/用途別市場規模...PARP inhibitors are a group of pharmacological inhibitors of the enzyme polymerase ADP ribosome (PARP).They are developed for multiple indications.PARP inhibitors can enhance the efficacy of radiotherapy, alkalization agents and platinum-based chemotherapy by inhibiting DNA damage repair and promoting apoptosis of tumor cells. Parp (Poly Adp-Ribose Polymerase) inhibitors is very effective in treating solid tumors and other diseases.Such as advanced ovarian cancer, fallopian tube cancer and primary peritoneal cancer.In 2018, the global PARP (Poly ADP-ribose Polymerase) Inhibitors market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR...
  • 多要素認証技術の世界市場：規模・現状・予測2019-2025
    DATA909X18730 / QYResearch / 2019年11月25日 / ※当調査レポートでは、多要素認証技術の世界市場について調査・分析し、多要素認証技術の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（2因子、3因子、4因子、5因子）、用途別（医療、金融機関、政府、エンターテインメント、通信、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の多要素認証技術市場動向 ・主要企業別マーケットシェア ・多要素認証技術の種類別市場規模2014-2019 （2因子、3因子、4因子、5因子） ・多要素認証技術の用途別市場規模2014-2019 （医療、金融機関、政府、エンターテインメント、通信、その他） ・多要素認証技術の北米市場：主要企業・種類別/用途別市場規模 ・多要素認証技術のヨーロッパ市場：主要企業・種類別/用途別市場規模...Multi-factor authentication (MFA) is an authentication method in which a computer user is granted access only after successfully presenting two or more pieces of evidence (or factors) to an authentication mechanism: knowledge (something the user and only the user knows), possession (something the user and only the user has), and inherence (something the user and only the user is).Multi-factor authentication (MFA) is a method of computer access control. Users need to pass two or more authentication mechanisms before they can get authorization to use computer resources. For example, a user needs to enter a PIN code, insert a bank card,...
  • 腫瘍壊死因子(TNF)阻害薬の世界市場：規模・現状・予測2019-2025
    DATA909X19054 / QYResearch / 2019年11月25日 / ※当調査レポートでは、腫瘍壊死因子(TNF)阻害薬の世界市場について調査・分析し、腫瘍壊死因子(TNF)阻害薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ヒュミラ、エンブレル、レミケード、シンポニー/シンポニーアリア、シムジア、バイオシミラー）、用途別（関節リウマチ、乾癬、乾癬性関節炎、クローン病、潰瘍性大腸炎、強直性脊椎炎、若年性特発性関節炎、化膿性汗腺炎、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の腫瘍壊死因子(TNF)阻害薬市場動向 ・主要企業別マーケットシェア ・腫瘍壊死因子(TNF)阻害薬の種類別市場規模2014-2019 （ヒュミラ、エンブレル、レミケード、シンポニー/シンポニーアリア、シムジア、バイオシミラー） ・腫瘍壊死因子(TNF)阻害薬の用途別市場規模2014-2019 （関節リウマチ、乾癬、乾癬性関節炎、クローン病、潰瘍性大腸炎、強直性脊椎炎、若年性特発性関節炎、化膿性汗腺炎、その他） ・腫瘍壊死因子(TNF)阻害薬の北米市場：主要企業・種類別/用途別市場規模 ・腫瘍壊死因子(TNF)阻害薬のヨーロッパ市場：主要企業・種類別/用途別市場規模...A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory response. TNF is involved in autoimmune and immune-mediated disorders such as rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease, psoriasis, hidradenitis suppurativa and refractory asthma, so TNF inhibitors may be used in their treatment. The important side effects of TNF inhibitors include lymphomas, infections (especially reactivation of latent tuberculosis), congestive heart failure, demyelinating disease, a lupus-like syndrome, induction of auto-antibodies, injection site reactions, and systemic side effects.The market growth is expected to be driven by new product launches, promising pipeline, increasing incidence of autoimmune diseases, and a significant rise in consumer awareness regarding...
  • 血管OCTA機器の世界市場：規模・現状・予測2019-2025
    DATA909X19072 / QYResearch / 2019年11月25日 / ※当調査レポートでは、血管OCTA機器の世界市場について調査・分析し、血管OCTA機器の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（SD-OCT、波長掃引型OCT、その他）、用途別（病院＆クリニック、眼科センター）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の血管OCTA機器市場動向 ・主要企業別マーケットシェア ・血管OCTA機器の種類別市場規模2014-2019 （SD-OCT、波長掃引型OCT、その他） ・血管OCTA機器の用途別市場規模2014-2019 （病院＆クリニック、眼科センター） ・血管OCTA機器の北米市場：主要企業・種類別/用途別市場規模 ・血管OCTA機器のヨーロッパ市場：主要企業・種類別/用途別市場規模...In 2018, the global Vascular OCTA Equipment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Vascular OCTA Equipment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Vascular OCTA Equipment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study ZEISS Canon Inc Heidelberg Engineering Topcon Medical Systems, Inc. Optovue Nidek Leica ... Market segment...

    • ◆H&Iグローバルリサーチのお客様（例）◆